These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 11518072)
41. St. John's wort: role of active compounds for its mechanism of action and efficacy. Butterweck V; Schmidt M Wien Med Wochenschr; 2007; 157(13-14):356-61. PubMed ID: 17704987 [TBL] [Abstract][Full Text] [Related]
42. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort. Buchholzer ML; Dvorak C; Chatterjee SS; Klein J J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077 [TBL] [Abstract][Full Text] [Related]
43. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study. Wright CW; Gott M; Grayson B; Hanna M; Smith AG; Sunter A; Neill JC J Psychopharmacol; 2003 Dec; 17(4):403-8. PubMed ID: 14870952 [TBL] [Abstract][Full Text] [Related]
44. Antidepressant activity of hyperforin conjugates of the St. John's wort, Hypericum perforatum Linn.: an experimental study. Muruganandam AV; Bhattacharya SK; Ghosal S Indian J Exp Biol; 2001 Dec; 39(12):1302-4. PubMed ID: 12018529 [TBL] [Abstract][Full Text] [Related]
45. Effects of the antidepressant St. John's wort (Hypericum perforatum) on rat and human vas deferens contractility. Capasso R; Borrelli F; Montanaro V; Altieri V; Capasso F; Izzo AA J Urol; 2005 Jun; 173(6):2194-7. PubMed ID: 15879886 [TBL] [Abstract][Full Text] [Related]
46. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts. Onoue S; Seto Y; Ochi M; Inoue R; Ito H; Hatano T; Yamada S Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201 [TBL] [Abstract][Full Text] [Related]
47. Batch-to-batch reproducibility of St. John's wort preparations. Wurglics M; Westerhoff K; Kaunzinger A; Wilke A; Baumeister A; Dressman J; Schubert-Zsilovecz M Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S152-6. PubMed ID: 11518067 [TBL] [Abstract][Full Text] [Related]
48. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin. Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409 [TBL] [Abstract][Full Text] [Related]
49. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment. Butterweck V; Korte B; Winterhoff H Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S2-7. PubMed ID: 11518068 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. Obach RS J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299 [TBL] [Abstract][Full Text] [Related]
51. Hypericin and hyperforin production in St. John's wort in vitro culture: influence of saccharose, polyethylene glycol, methyl jasmonate, and Agrobacterium tumefaciens. Pavlík M; Vacek J; Klejdus B; Kuban V J Agric Food Chem; 2007 Jul; 55(15):6147-53. PubMed ID: 17608493 [TBL] [Abstract][Full Text] [Related]
52. The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men. Siepmann M; Krause S; Joraschky P; Mück-Weymann M; Kirch W Br J Clin Pharmacol; 2002 Sep; 54(3):277-82. PubMed ID: 12236848 [TBL] [Abstract][Full Text] [Related]
53. Variability in PXR-mediated induction of CYP3A4 by commercial preparations and dry extracts of St. John's wort. Gödtel-Armbrust U; Metzger A; Kroll U; Kelber O; Wojnowski L Naunyn Schmiedebergs Arch Pharmacol; 2007 Aug; 375(6):377-82. PubMed ID: 17593354 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of synaptosomal uptake inhibition of most relevant constituents of St. John's wort. Wonnemann M; Singer A; Siebert B; Müller WE Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S148-51. PubMed ID: 11518066 [TBL] [Abstract][Full Text] [Related]
55. Role of hyperforin in the pharmacological activities of St. John's Wort. Zanoli P CNS Drug Rev; 2004; 10(3):203-18. PubMed ID: 15492771 [TBL] [Abstract][Full Text] [Related]
56. The main components of St John's Wort inhibit low-density lipoprotein atherogenic modification: a beneficial "side effect" of an OTC antidepressant drug? Laggner H; Schreier S; Hermann M; Exner M; Mühl A; Gmeiner BM; Kapiotis S Free Radic Res; 2007 Feb; 41(2):234-41. PubMed ID: 17364950 [TBL] [Abstract][Full Text] [Related]
57. Extracts of St. John's wort and various constituents affect beta-adrenergic binding in rat frontal cortex. Simbrey K; Winterhoff H; Butterweck V Life Sci; 2004 Jan; 74(8):1027-38. PubMed ID: 14672758 [TBL] [Abstract][Full Text] [Related]
58. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro. Hostanska K; Reichling J; Bommer S; Weber M; Saller R Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257 [TBL] [Abstract][Full Text] [Related]
59. Fast high-performance liquid chromatographic analysis of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts. Tolonen A; Hohtola A; Jalonen J Phytochem Anal; 2003; 14(5):306-9. PubMed ID: 14516003 [TBL] [Abstract][Full Text] [Related]
60. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of Hypericum perforatum on alcohol intake in rats. Perfumi M; Panocka I; Ciccocioppo R; Vitali D; Froldi R; Massi M Alcohol Alcohol; 2001; 36(3):199-206. PubMed ID: 11373255 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]